Abstract
The use of prostate specific antigen (PSA) test could have a large impact on the incidence of prostate cancer in the UK. Over a period of 1 year (1999), 3.5% out of 160 015 men aged > 45 on a GP database, who had no previous record of prostate cancer, had a PSA test. Of the tested men, 21.3% had a PSA > 4 ng/ml. Future data need to distinguish between men with and without symptoms. © 2001 Cancer Research Campaign www.bjcancer.com
Similar content being viewed by others
Article PDF
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Chamberlain, J, Melia, J, Moss, S & Brown, J (1997). Report prepared for the Health Technology Assessment Panel of the NHS Executive on the diagnosis, management, treatment and costs of prostate cancer in England and Wales. Br J Urol, 79, 1–32.
Collins, MM, Stafford, RS & Barry, MJ (2000). Age-specific patterns of prostate-specific antigen testing among primary care physician visits. J Fam Pract, 49, 169–172.
Jacobsen, SJ, Katusic, SK, Bergstralh, EJ, Oesterling, JE, Ohrt, D, Klee, GIG, Chute, CG & Lieber, MM (1995). Incidence of prostate cancer diagnosis in the eras before and after serum prostate- specific antigen testing. J Am Med Assoc, 274, 1445–1449.
Maattanen, L, Auvinen, A, Stenman, UH, Rannikko, S, Tammela, T, Aro, J, Juusela, H & Hakama, M (1999). European randomized study of prostate cancer screening: first year results of the Finnish trial. Br J Cancer, 79, 1210–1214.
Oliver, SE, Gunnell, D & Donovan, JL (2000). Comparison of trends in prostate-cancer mortality in England and Wales and the USA. Lancet, 355, 1788–1789.
Author information
Authors and Affiliations
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Melia, J., Moss, S. Survey of the rate of PSA testing in general practice. Br J Cancer 85, 656–657 (2001). https://doi.org/10.1054/bjoc.2001.1962
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1054/bjoc.2001.1962
Keywords
This article is cited by
-
Fatal prostate cancer incidence trends in the United States and England by race, stage, and treatment
British Journal of Cancer (2020)
-
Trends in prostate specific antigen testing in Ireland: lessons from a country without guidelines
Irish Journal of Medical Science (2010)
-
Factors prompting PSA-testing of asymptomatic men in a country with no guidelines: a national survey of general practitioners
BMC Family Practice (2009)
-
Excess cases of prostate cancer and estimated overdiagnosis associated with PSA testing in East Anglia
British Journal of Cancer (2006)
-
PSA testing for prostate cancer: an online survey of the views and reported practice of General Practitioners in the UK
BMC Family Practice (2005)